Managing FCS is notoriously difficult. With standard lipid-lowering therapies often failing, strict diet has historically been the only tool. In this CME program, Dr. Shapiro reviews the pathophysiology and strategies to reduce pancreatitis risk. Watch the full video ➡️ https://www.facebook.com/watch/live/?ref=watch_permalink&v=1171021224648318 #CME | Medscape

Oral TKI or IV ADC for HER2 NSCLC? The first oral medication for this disease, Zongertinib, is now approved, joining established IV therapies like Trastuzumab deruxtecan. Our experts discuss how to choose ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape

Liver MRI: News From the Front Lines | Medscape

Cardio-Kidney-Metabolic Challenge: Improving Patient Outcomes | Medscape

Reframing Heart Failure Care: Amplifying Patient Voices in the Evolving Treatment Landscape | Medscape

Breaking News in IBD: Advancing Confidence in Optimizing Subcutaneous Anti-TNF Treatment Across the Care Continuum | Medscape